NLS Pharmaceutics Ltd (NLSP)
0.1533
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
0.153
0.00 (0.00%)
After-Hours: 20:00
NLS Pharmaceutics Cash from Financing (Quarterly)
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
Date | Value |
---|
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Financing (Quarterly) Benchmarks
AC Immune SA | -0.7872M |
CRISPR Therapeutics AG | 305.93M |
Addex Therapeutics Ltd | -0.1643M |
Molecular Partners AG | -0.3157M |
MoonLake Immunotherapeutics | 50.98M |
Cash from Financing (Quarterly) Related Metrics
Free Cash Flow | -9.684M |
Free Cash Flow Yield | -154.7% |